 Home > Medical News > Latest Medical News > Pfizer/BioNTech mRNA vaccine to prevent influenza enters the clinic

Pfizer/BioNTech mRNA vaccine to prevent influenza enters the clinic

 Last Update: 2021-11-05
 Source: Internet
 Author: User

Tags

long flu vaccine effective

venom production company

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Today, Pfizer announced that the mRNA quadrivalent influenza vaccine jointly developed by the company and BioNTech has completed the first batch of adult volunteers in a phase 1 clinical trial

Conventional seasonal influenza vaccines are generally made by growing the virus in chicken eggs or mammalian cells and inactivating them into vaccines

Even if the vaccine strain is well matched with the circulating virus strain, the protection rate of the current seasonal vaccine against the circulating strain is usually 40% to 60%

The mRNA-based influenza vaccine design only requires the gene sequence of the virus

Reference materials:

[1] Pfizer Starts Study of mRNA-Based Next Generation Flu Vaccine Program.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Express to prevent influenza, Pfizer/BioNTech mRNA vaccine enters the clinic

10-11

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.

Pfizer/BioNTech mRNA vaccine to prevent influenza enters the clinic

Related Articles

Express to prevent influenza, Pfizer/BioNTech mRNA vaccine enters the clinic